Literature DB >> 19800725

Emerging treatments for PTSD.

Judith Cukor1, Josh Spitalnick, Joann Difede, Albert Rizzo, Barbara O Rothbaum.   

Abstract

Recent innovations in posttraumatic stress disorder (PTSD) research have identified new treatments with significant potential, as well as novel enhancements to empirically-validated treatments. This paper reviews emerging psychotherapeutic and pharmacologic interventions for the treatment of PTSD. It examines the evidence for a range of interventions, from social and family-based treatments to technological-based treatments. It describes recent findings regarding novel pharmacologic approaches including propranolol, ketamine, prazosin, and methylenedioxymethamphetamine. Special emphasis is given to the description of virtual reality and D-cycloserine as enhancements to prolonged exposure therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19800725     DOI: 10.1016/j.cpr.2009.09.001

Source DB:  PubMed          Journal:  Clin Psychol Rev        ISSN: 0272-7358


  41 in total

1.  Increasing histone acetylation in the hippocampus-infralimbic network enhances fear extinction.

Authors:  James M Stafford; Jonathan D Raybuck; Andrey E Ryabinin; K Matthew Lattal
Journal:  Biol Psychiatry       Date:  2012-01-29       Impact factor: 13.382

Review 2.  Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.

Authors:  Colin N Haile; James J Mahoney; Thomas F Newton; Richard De La Garza
Journal:  Pharmacol Ther       Date:  2012-01-31       Impact factor: 12.310

3.  Best practice guide for the treatment of nightmare disorder in adults.

Authors:  R Nisha Aurora; Rochelle S Zak; Sanford H Auerbach; Kenneth R Casey; Susmita Chowdhuri; Anoop Karippot; Rama K Maganti; Kannan Ramar; David A Kristo; Sabin R Bista; Carin I Lamm; Timothy I Morgenthaler
Journal:  J Clin Sleep Med       Date:  2010-08-15       Impact factor: 4.062

4.  Unpaired extinction: implications for treating post-traumatic stress disorder.

Authors:  Bernard G Schreurs; Carrie A Smith-Bell; Lauren B Burhans
Journal:  J Psychiatr Res       Date:  2010-11-12       Impact factor: 4.791

Review 5.  Treatment of Post-Traumatic Stress Disorders with the Alpha-1 Adrenergic Antagonist Prazosin.

Authors:  Philippe Yves Rémy Simon; Pierre-François Rousseau
Journal:  Can J Psychiatry       Date:  2016-07-19       Impact factor: 4.356

6.  PTSD and Cannabis-Related Coping Among Recent Veterans in New York City.

Authors:  Luther Elliott; Andrew Golub; Alexander Bennett; Honoria Guarino
Journal:  Contemp Drug Probl       Date:  2015-03-02

7.  Neuroethics: Give memory-altering drugs a chance.

Authors:  Adam Kolber
Journal:  Nature       Date:  2011-08-17       Impact factor: 49.962

Review 8.  From Pavlov to PTSD: the extinction of conditioned fear in rodents, humans, and anxiety disorders.

Authors:  Michael B VanElzakker; M Kathryn Dahlgren; F Caroline Davis; Stacey Dubois; Lisa M Shin
Journal:  Neurobiol Learn Mem       Date:  2013-12-07       Impact factor: 2.877

9.  Beta-blockers may reduce intrusive thoughts in newly diagnosed cancer patients.

Authors:  Monica E Lindgren; Christopher P Fagundes; Catherine M Alfano; Stephen P Povoski; Doreen M Agnese; Mark W Arnold; William B Farrar; Lisa D Yee; William E Carson; Carl R Schmidt; Janice K Kiecolt-Glaser
Journal:  Psychooncology       Date:  2012-12-17       Impact factor: 3.894

Review 10.  Recent progress in understanding the pathophysiology of post-traumatic stress disorder: implications for targeted pharmacological treatment.

Authors:  Christopher R Bailey; Elisabeth Cordell; Sean M Sobin; Alexander Neumeister
Journal:  CNS Drugs       Date:  2013-03       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.